Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China · Delayed Price · Currency is CNY

10.61

-0.23 (-2.12%)

Sep 10, 2026, 3:00 PM CST

Market Cap	4.66B -7.3%
Revenue (ttm)	1.87B +9.9%
Net Income	334.81M +16.4%
EPS	0.76 +17.2%
Shares Out	439.08M
PE Ratio	13.95
Forward PE	12.78
Dividend	0.50 (4.61%)
Ex-Dividend Date	Sep 11, 2026

Volume	7,244,700
Open	10.83
Previous Close	10.84
Day's Range	10.55 - 10.84
52-Week Range	8.64 - 13.50
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets;... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 1,868

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603998

Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements